GET THE APP
Prognostic Factor Review Articles | Open Access Journals
Journal of Clinical Case Reports

Journal of Clinical Case Reports

ISSN: 2165-7920

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Prognostic Factor Review Articles

Prognostic variables are those estimations accessible at the hour of finding that are related with ailment free or by and large endurance and can regularly be utilized to anticipate the common history of the tumor. Enhancing treatment dependent on prognostic components assumes a significant job in the administration of female bosom disease. The standard prognostic factors as of now applied in new instances of bosom disease incorporate axillary lymph hub status, histologic subtype, tumor size, atomic evaluation, hormone receptor status, proportions of expansion, and sub-atomic markers, for example, HER2 overexpression. Of these, the nearness or nonappearance of metastatic carcinoma in the axillary lymph hubs is the most impressive prognostic factor for patients with essential bosom malignant growth. In male bosom malignancy, tumor size, and lymph hub contribution are two clear prognostic elements for male patients with bosom cancer.7 Men with tumors estimating 2–5 cm have a 40% higher danger of death than men with tumors <2 cm in most extreme diameter.7 Similarly, men with lymph hub association have a half higher danger of death than those without lymph hub involvement.7 There are various reports in male bosom disease that additionally correspond result with nodal inclusion.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Clinical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 1345

Journal of Clinical Case Reports received 1345 citations as per Google Scholar report

Citation image
Journal of Clinical Case Reports peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
Rituximab as First-Line Therapy in Severe Lupus Erythematosus with Neuropsychiatric and Renal Involvement: A Case-Report and Review of the Literature
 

Open Access Journals

arrow_upward arrow_upward